The new Encephalopathy Autoimmune Evaluation is now available from Mayo Medical Laboratories. This test should be considered in patients with a rapid-onset of one or more cognitive symptoms, seizures, psychiatric disturbance, behavioral disturbance, particularly in patients who have a background history of autoimmunity, cancer or smoking history.